← Back to News List

ADA: Orforglipron beneficial for reducing HbA1c in type 2 diabetes

MedicalXpress | juin 16, 2026
News Cover

Orforglipron is beneficial for blood glucose control in individuals with type 2 diabetes using metformin or taking insulin glargine, according to two studies published online June 8 in The Lancet and the JAMA to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.

This article was originally published by MedicalXpress. For more details, images, and references:

Read Full Original Article ↗